FRIDAY, Aug. 12, 2022 (HealthDay News) – The popular diabetes drug Januvia may contain traces of a probable carcinogen, but patients should keep using the medication because it could be dangerous to stop taking it, the U.S. Food and Drug Administration announced this week. Despite the discovery that Nitroso-STG-19 (NTTP)Continue Reading
FRIDAY, Aug. 5, 2022 (HealthDay News) — Elevated levels of a specific protein appear to be linked to an increased risk of developing diabetes and dying from cancer, a new study finds. High levels of prostasin — mainly found in epithelial cells, which line the surfaces and organs of theContinue Reading
FRIDAY, Aug. 5, 2022 (HealthDay News) – Kids with type 1 diabetes and their closest relatives are more likely to experience mental health issues than people without the disease, Swedish researchers report. “Many clinicians assume intuitively that diabetes in a child negatively affects the mental health of both the patientContinue Reading
WEDNESDAY, July 27, 2022 (HealthDay News) — A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients’ insulin resistance, according to a small-scale clinical trial. Bipolar patients who responded to the drug metformin experienced improvement in their mood disorder as their insulin resistance decreased, said lead researcherContinue Reading
TUESDAY, July 26, 2022 (HealthDay News) — Intermittent fasting might help people with type 2 diabetes better control their blood sugar levels, a new study has found. People with diabetes who restricted their eating to within a daily 10-hour window wound up with blood sugar levels in the normal rangeContinue Reading
SUNDAY, July 24, 2022 (HealthDay News) — Living in a region where tropical storms, hurricanes or other weather emergencies are likely means being ready for a quick evacuation. “Part of preparedness is having a plan,” said Dr. James McDeavitt, executive vice president and dean of clinical affairs at Baylor CollegeContinue Reading
WEDNESDAY, July 20, 2022 (HealthDay News) — In a mix of bad and good news, a new large study confirms that COVID can raise the risks of new-onset heart trouble and diabetes — though those threats typically wane again after a few months. The study, of nearly 430,000 British COVIDContinue Reading
TUESDAY, July 19, 2022 (HealthDay News) — Deaths from heart-related causes have dropped over the past 20 years, though differences persist by race and ethnicity as well as where people live and their access to care. The U.S. National Institutes of Health (NIH), which partially funded the research, detailed theContinue Reading
FRIDAY, July 15, 2022 (HealthDay News) — An off-brand medication for diabetic macular edema might prove just as effective in early treatment as its more expensive alternative, potentially saving patients thousands of dollars, new research suggests. The vision condition is a common complication of poorly controlled diabetes, which can damageContinue Reading
FRIDAY, July 8, 2022 (HealthDay News) — California Governor Gavin Newsom announced Thursday that the state will spend $100 million to produce its own insulin. The innovative push comes after years of astronomical prices for the drug have made it nearly impossible for many people with diabetes to afford theContinue Reading